Five things to know:
1. KKR has raised $10 billion in the last two months, signaling interest in more transactions.
2. The firm is ready “to not only play defense but also [play] more offense,” according to Scott Nuttall, KKR’s co-president.
3. Specifically, KKR is looking to provide liquidity to struggling companies and working with its portfolio companies to seize growth opportunities.
4. KKR’s private equity portfolio fell 12 percent in the first quarter, one of many areas in which the firm saw declines due to the COVID-19 crisis.
5. Envision Healthcare has been hit particularly hard, incurring steep losses from COVID-19-related elective surgery bans.
More articles on practice management:
AAOS, OREF partner to drive funding for biologic, total joint replacement research
NuVasive Q1 net income drops 43.6%, shares down 27% since start of year
Dr. Charles Branch Jr.: Imaging, patient engagement big opportunities in spine post-pandemic
